205 related articles for article (PubMed ID: 12824898)
1. NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics.
Matsumoto K; Nakamura T
Cancer Sci; 2003 Apr; 94(4):321-7. PubMed ID: 12824898
[TBL] [Abstract][Full Text] [Related]
2. NK4 gene therapy targeting HGF-Met and angiogenesis.
Matsumoto K; Nakamura T
Front Biosci; 2008 Jan; 13():1943-51. PubMed ID: 17981681
[TBL] [Abstract][Full Text] [Related]
3. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and significance of bifunctional NK4 in cancer treatment.
Matsumoto K; Nakamura T
Biochem Biophys Res Commun; 2005 Jul; 333(2):316-27. PubMed ID: 15950947
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
[TBL] [Abstract][Full Text] [Related]
7. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
[TBL] [Abstract][Full Text] [Related]
8. Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.
Maehara N; Nagai E; Mizumoto K; Sato N; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
Clin Exp Metastasis; 2002; 19(5):417-26. PubMed ID: 12198770
[TBL] [Abstract][Full Text] [Related]
9. HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics.
Mizuno S; Nakamura T
Int J Mol Sci; 2013 Jan; 14(1):888-919. PubMed ID: 23296269
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer approach with NK4: Bivalent action and mechanisms.
Nakamura T; Sakai K; Nakamura T; Matsumoto K
Anticancer Agents Med Chem; 2010 Jan; 10(1):36-46. PubMed ID: 20015005
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
Date K; Matsumoto K; Kuba K; Shimura H; Tanaka M; Nakamura T
Oncogene; 1998 Dec; 17(23):3045-54. PubMed ID: 9881707
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
[TBL] [Abstract][Full Text] [Related]
13. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
[TBL] [Abstract][Full Text] [Related]
14. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
Lai RX; Yuan SZ; Nakamura T
Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
[TBL] [Abstract][Full Text] [Related]
15. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
Davies G; Mason MD; Martin TA; Parr C; Watkins G; Lane J; Matsumoto K; Nakamura T; Jiang WG
Int J Cancer; 2003 Sep; 106(3):348-54. PubMed ID: 12845672
[TBL] [Abstract][Full Text] [Related]
16. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells.
Parr C; Hiscox S; Nakamura T; Matsumoto K; Jiang WG
Int J Cancer; 2000 Feb; 85(4):563-70. PubMed ID: 10699931
[TBL] [Abstract][Full Text] [Related]
17. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
Martin TA; Parr C; Davies G; Watkins G; Lane J; Matsumoto K; Nakamura T; Mansel RE; Jiang WG
Carcinogenesis; 2003 Aug; 24(8):1317-23. PubMed ID: 12807719
[TBL] [Abstract][Full Text] [Related]
18. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.
Maemondo M; Narumi K; Saijo Y; Usui K; Tahara M; Tazawa R; Hagiwara K; Matsumoto K; Nakamura T; Nukiwa T
Mol Ther; 2002 Feb; 5(2):177-85. PubMed ID: 11829525
[TBL] [Abstract][Full Text] [Related]
19. NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.
Ge X; Wang Y; Wang Y; Li Q; Yu H; Miao L
Dig Dis Sci; 2013 Jun; 58(6):1636-43. PubMed ID: 23314853
[TBL] [Abstract][Full Text] [Related]
20. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
Maehara N; Matsumoto K; Kuba K; Mizumoto K; Tanaka M; Nakamura T
Br J Cancer; 2001 Mar; 84(6):864-73. PubMed ID: 11259105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]